课题基金 / 基金详情

项目摘要

项目成果

Dylan Dodd的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The human distal gut microbiome is an extraordinary example of a mutualistic relationship wherein trillions of microbes ferment dietary and host-derived carbohydrates and the products of fermentation contribute to nutrient acquisition, gut epithelial health, and immune system development. The NIH-funded human microbiome project will generate nearly 1000 reference genomes from cultured and non-cultured microbes, and will supplement this data with DNA sequencing of microbial samples taken from human subjects. Glycoside hydrolases (GHs) comprise a significant proportion of the genes encoded by microbial genomes within the human distal gut microbiome and contribute to the depolymerization of recalcitrant dietary polysaccharides. A recent metagenomic analysis of the human distal gut microbiome revealed that of the 81 GH families present in the distal gut microbiome, GH family 3 was the most highly represented, which indicates that this gene family is important for carbohydrate utilization by the gut microflora. A number of different functional activities have been described for GH family 3 enzymes although the molecular determinants that define substrate specificity for these enzymes have not been elucidated. The long-term goal of the proposed research is to provide insight into the role of the GH family 3 genes in the metabolic repertoire of human gut microorganisms. In aim 1 we will characterize the substrate specificities of four GH family 3 enzymes from the bacterium Prevotella bryantii Bi4 using a library of natural plant cell wall derived oligosaccharides. In aim 2 we will employ a directed evolution approach for identifying amino acid residues that contribute to substrate specificity for one of these GH family 3 enzymes from P. bryantii Bi4. Results from the proposed studies will provide insight into the molecular determinants of substrate specificity for GH family 3 genes and will allow us to place this important gene family in the context of the metabolic repertoire of the gut-associated microflora.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/j.1365-2958.2010.07473.x
发表时间: 2011-01
期刊: Molecular microbiology
影响因子: 3.6
作者: [Dodd D, Mackie RI, Cann IK]
通讯作者: Cann IK
DOI: 10.1016/s0065-2164(10)70001-0
发表时间: 2010
期刊: Advances in applied microbiology
影响因子: --
作者: [Yeoman CJ, Han Y, Dodd D, Schroeder CM, Mackie RI, Cann IK]
通讯作者: Cann IK
Microbiota-based probiotics to treat inborn errors in metabolism
  • 批准号:
    10365689
  • 项目类别:
  • 资助金额:
    $58.79万
  • 财政年份:
    2022
  • 负责人:
    Dylan Dodd
  • 依托单位:
Microbiota-based probiotics to treat inborn errors in metabolism
  • 批准号:
    10574622
  • 项目类别:
  • 资助金额:
    $58.79万
  • 财政年份:
    2022
  • 负责人:
    Dylan Dodd
  • 依托单位:
Physiology of bacterial metabolism in the human gut microbiome
  • 批准号:
    10460570
  • 项目类别:
  • 资助金额:
    $39.73万
  • 财政年份:
    2021
  • 负责人:
    Dylan Dodd
  • 依托单位:
Physiology of bacterial metabolism in the human gut microbiome
  • 批准号:
    10686712
  • 项目类别:
  • 资助金额:
    $4.8万
  • 财政年份:
    2021
  • 负责人:
    Dylan Dodd
  • 依托单位:
海外基金